nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—restless legs syndrome—Pregabalin—epilepsy syndrome	0.184	0.267	CpDpCtD
Carbidopa—restless legs syndrome—Carbamazepine—epilepsy syndrome	0.164	0.238	CpDpCtD
Carbidopa—restless legs syndrome—Clonazepam—epilepsy syndrome	0.131	0.19	CpDpCtD
Carbidopa—restless legs syndrome—Gabapentin—epilepsy syndrome	0.105	0.153	CpDpCtD
Carbidopa—Parkinson's disease—Clonazepam—epilepsy syndrome	0.0574	0.0835	CpDpCtD
Carbidopa—Parkinson's disease—Gabapentin—epilepsy syndrome	0.0463	0.0673	CpDpCtD
Carbidopa—DDC—telencephalic ventricle—epilepsy syndrome	0.0108	0.28	CbGeAlD
Carbidopa—DDC—ganglion—epilepsy syndrome	0.00673	0.174	CbGeAlD
Carbidopa—DDC—hindbrain—epilepsy syndrome	0.00511	0.132	CbGeAlD
Carbidopa—DDC—Catecholamine biosynthesis—TH—epilepsy syndrome	0.00471	0.0652	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—KCNK3—epilepsy syndrome	0.00434	0.06	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—KCNK9—epilepsy syndrome	0.00434	0.06	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—HTRA2—epilepsy syndrome	0.00295	0.0408	CbGpPWpGaD
Carbidopa—DDC—brainstem—epilepsy syndrome	0.00293	0.0757	CbGeAlD
Carbidopa—DDC—Biogenic Amine Synthesis—GAD2—epilepsy syndrome	0.00285	0.0394	CbGpPWpGaD
Carbidopa—DDC—forebrain—epilepsy syndrome	0.00282	0.0731	CbGeAlD
Carbidopa—DDC—Dopaminergic Neurogenesis—ASCL1—epilepsy syndrome	0.0027	0.0374	CbGpPWpGaD
Carbidopa—DDC—telencephalon—epilepsy syndrome	0.0026	0.0672	CbGeAlD
Carbidopa—DDC—Tryptophan metabolism—WARS—epilepsy syndrome	0.00253	0.0351	CbGpPWpGaD
Carbidopa—DDC—Biogenic Amine Synthesis—GAD1—epilepsy syndrome	0.00247	0.0342	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—RET—epilepsy syndrome	0.0021	0.0291	CbGpPWpGaD
Carbidopa—Metyrosine—TH—epilepsy syndrome	0.00192	0.529	CrCbGaD
Carbidopa—DDC—midbrain—epilepsy syndrome	0.00186	0.0482	CbGeAlD
Carbidopa—DDC—Dopamine metabolism—TH—epilepsy syndrome	0.00184	0.0254	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNB2—epilepsy syndrome	0.00166	0.023	CbGpPWpGaD
Carbidopa—DDC—Biogenic Amine Synthesis—TH—epilepsy syndrome	0.00164	0.0227	CbGpPWpGaD
Carbidopa—DDC—head—epilepsy syndrome	0.00162	0.0418	CbGeAlD
Carbidopa—DDC—Amine-derived hormones—TH—epilepsy syndrome	0.00156	0.0215	CbGpPWpGaD
Carbidopa—DDC—nervous system—epilepsy syndrome	0.00153	0.0397	CbGeAlD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA4—epilepsy syndrome	0.00151	0.0209	CbGpPWpGaD
Carbidopa—DDC—central nervous system—epilepsy syndrome	0.00148	0.0382	CbGeAlD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP6—epilepsy syndrome	0.00128	0.0178	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SNTA1—epilepsy syndrome	0.00126	0.0174	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—TH—epilepsy syndrome	0.00125	0.0173	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP2—epilepsy syndrome	0.00123	0.017	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—UBE3A—epilepsy syndrome	0.00118	0.0163	CbGpPWpGaD
Carbidopa—DDC—brain—epilepsy syndrome	0.00117	0.0303	CbGeAlD
Carbidopa—DDC—Parkinsons Disease Pathway—PARK2—epilepsy syndrome	0.00108	0.015	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—TH—epilepsy syndrome	0.000941	0.013	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GLUD1—epilepsy syndrome	0.000822	0.0114	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—SIX3—epilepsy syndrome	0.000779	0.0108	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—KCND2—epilepsy syndrome	0.000779	0.0108	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PROX1—epilepsy syndrome	0.000779	0.0108	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—TH—epilepsy syndrome	0.000779	0.0108	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GAMT—epilepsy syndrome	0.000751	0.0104	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—ASCL1—epilepsy syndrome	0.000723	0.01	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—MECP2—epilepsy syndrome	0.000723	0.01	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—QDPR—epilepsy syndrome	0.000699	0.00966	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC6A8—epilepsy syndrome	0.000623	0.00861	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000562	0.00778	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CAT—epilepsy syndrome	0.00055	0.00761	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000548	0.00758	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NTRK3—epilepsy syndrome	0.000502	0.00694	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	0.000501	0.00693	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	0.000501	0.00693	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	0.000482	0.00667	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	0.000466	0.00644	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—ALDH7A1—epilepsy syndrome	0.00045	0.00623	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GLUL—epilepsy syndrome	0.000423	0.00586	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NPY2R—epilepsy syndrome	0.000409	0.00566	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	0.000396	0.00548	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	0.000396	0.00548	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	0.000372	0.00515	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—UBE3A—epilepsy syndrome	0.000363	0.00502	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—CHRM1—epilepsy syndrome	0.000348	0.00481	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—KCNMA1—epilepsy syndrome	0.000339	0.00469	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	0.000334	0.00463	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—epilepsy syndrome	0.000317	0.00438	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—JUND—epilepsy syndrome	0.000304	0.00421	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	0.000304	0.0042	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—MAPK10—epilepsy syndrome	0.000291	0.00402	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	0.000282	0.0039	CbGpPWpGaD
Carbidopa—Methyldopa—ADRA2A—epilepsy syndrome	0.000277	0.0763	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000275	0.0038	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000275	0.0038	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000273	0.00378	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—CHRNB2—epilepsy syndrome	0.000273	0.00378	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000252	0.00348	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—CRH—epilepsy syndrome	0.000248	0.00343	CbGpPWpGaD
Carbidopa—Levonordefrin—ADRA2A—epilepsy syndrome	0.000246	0.0675	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—SLC6A4—epilepsy syndrome	0.00023	0.00319	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—TH—epilepsy syndrome	0.000217	0.003	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000208	0.00288	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TH—epilepsy syndrome	0.000205	0.00284	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000205	0.00283	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—HTR7—epilepsy syndrome	0.000202	0.00279	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CA13—epilepsy syndrome	0.000199	0.00275	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000197	0.00272	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.00019	0.00263	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000184	0.00254	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000182	0.00252	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000181	0.0025	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	0.000173	0.0024	CbGpPWpGaD
Carbidopa—Droxidopa—ADRA2A—epilepsy syndrome	0.000173	0.0476	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—AVP—epilepsy syndrome	0.00017	0.00235	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—SIRT1—epilepsy syndrome	0.000167	0.0023	CbGpPWpGaD
Carbidopa—Dopamine—HTR7—epilepsy syndrome	0.000158	0.0434	CrCbGaD
Carbidopa—DDC—Metabolism—GLUD1—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CERS1—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PDXK—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—FAR1—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ADK—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—L2HGDH—epilepsy syndrome	0.000151	0.00209	CbGpPWpGaD
Carbidopa—Norepinephrine—ADRA2A—epilepsy syndrome	0.000146	0.0401	CrCbGaD
Carbidopa—DDC—Metabolism—PNPO—epilepsy syndrome	0.000138	0.00191	CbGpPWpGaD
Carbidopa—DDC—Metabolism—EPM2A—epilepsy syndrome	0.000138	0.00191	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NHLRC1—epilepsy syndrome	0.000138	0.00191	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GAMT—epilepsy syndrome	0.000138	0.00191	CbGpPWpGaD
Carbidopa—Epinephrine—ADRA2A—epilepsy syndrome	0.000132	0.0363	CrCbGaD
Carbidopa—DDC—Metabolism—CA4—epilepsy syndrome	0.000128	0.00177	CbGpPWpGaD
Carbidopa—DDC—Metabolism—QDPR—epilepsy syndrome	0.000128	0.00177	CbGpPWpGaD
Carbidopa—Epinephrine—TNF—epilepsy syndrome	0.000125	0.0345	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—NOS2—epilepsy syndrome	0.000122	0.00169	CbGpPWpGaD
Carbidopa—DDC—Metabolism—COX3—epilepsy syndrome	0.000121	0.00167	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PFKL—epilepsy syndrome	0.000114	0.00158	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLCO1A2—epilepsy syndrome	0.000114	0.00158	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CACNA2D2—epilepsy syndrome	0.000114	0.00158	CbGpPWpGaD
Carbidopa—DDC—Metabolism—KCNB1—epilepsy syndrome	0.000114	0.00158	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC6A8—epilepsy syndrome	0.000114	0.00158	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NEU1—epilepsy syndrome	0.000105	0.00145	CbGpPWpGaD
Carbidopa—DDC—Metabolism—UPB1—epilepsy syndrome	0.000105	0.00145	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ATIC—epilepsy syndrome	0.000105	0.00145	CbGpPWpGaD
Carbidopa—Mesalazine—PTGS2—epilepsy syndrome	0.000103	0.0284	CrCbGaD
Carbidopa—Dopamine—SLC6A4—epilepsy syndrome	0.000103	0.0284	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	0.000103	0.00142	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	0.000102	0.00142	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD17B4—epilepsy syndrome	0.000101	0.00139	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	9.94e-05	0.00138	CbGpPWpGaD
Carbidopa—Dopamine—CYP2C19—epilepsy syndrome	9.8e-05	0.0269	CrCbGaD
Carbidopa—DDC—Metabolism—GBE1—epilepsy syndrome	9.72e-05	0.00134	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPP1R3C—epilepsy syndrome	9.72e-05	0.00134	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ASAH1—epilepsy syndrome	9.14e-05	0.00126	CbGpPWpGaD
Carbidopa—DDC—Metabolism—STXBP1—epilepsy syndrome	8.89e-05	0.00123	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	8.69e-05	0.0012	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NT5E—epilepsy syndrome	8.66e-05	0.0012	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALAD—epilepsy syndrome	8.66e-05	0.0012	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALDH7A1—epilepsy syndrome	8.27e-05	0.00114	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CACNA1A—epilepsy syndrome	8.27e-05	0.00114	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—JUN—epilepsy syndrome	8.12e-05	0.00112	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ST3GAL3—epilepsy syndrome	8.09e-05	0.00112	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ADSL—epilepsy syndrome	7.92e-05	0.0011	CbGpPWpGaD
Carbidopa—L-DOPA—CYP2D6—epilepsy syndrome	7.81e-05	0.0215	CrCbGaD
Carbidopa—DDC—Metabolism—GLUL—epilepsy syndrome	7.77e-05	0.00108	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CACNA1D—epilepsy syndrome	7.63e-05	0.00106	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	7.44e-05	0.00103	CbGpPWpGaD
Carbidopa—Dopamine—CYP2D6—epilepsy syndrome	7.26e-05	0.02	CrCbGaD
Carbidopa—DDC—Metabolism—TXNRD1—epilepsy syndrome	7.14e-05	0.000987	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AQP1—epilepsy syndrome	6.93e-05	0.000958	CbGpPWpGaD
Carbidopa—DDC—Metabolism—KCNJ11—epilepsy syndrome	6.26e-05	0.000867	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CHRM3—epilepsy syndrome	6.26e-05	0.000867	CbGpPWpGaD
Carbidopa—Diarrhoea—Zonisamide—epilepsy syndrome	5.21e-05	0.000263	CcSEcCtD
Carbidopa—Loss of consciousness—Pregabalin—epilepsy syndrome	5.2e-05	0.000262	CcSEcCtD
Carbidopa—Asthenia—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.000262	CcSEcCtD
Carbidopa—Pruritus—Clonazepam—epilepsy syndrome	5.19e-05	0.000262	CcSEcCtD
Carbidopa—Vomiting—Vigabatrin—epilepsy syndrome	5.19e-05	0.000262	CcSEcCtD
Carbidopa—Urinary tract disorder—Topiramate—epilepsy syndrome	5.18e-05	0.000261	CcSEcCtD
Carbidopa—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.16e-05	0.00026	CcSEcCtD
Carbidopa—Cough—Pregabalin—epilepsy syndrome	5.16e-05	0.00026	CcSEcCtD
Carbidopa—Pruritus—Phenytoin—epilepsy syndrome	5.15e-05	0.00026	CcSEcCtD
Carbidopa—Nausea—Levetiracetam—epilepsy syndrome	5.15e-05	0.00026	CcSEcCtD
Carbidopa—Rash—Vigabatrin—epilepsy syndrome	5.14e-05	0.000259	CcSEcCtD
Carbidopa—Dizziness—Felbamate—epilepsy syndrome	5.14e-05	0.000259	CcSEcCtD
Carbidopa—Dermatitis—Vigabatrin—epilepsy syndrome	5.14e-05	0.000259	CcSEcCtD
Carbidopa—Urethral disorder—Topiramate—epilepsy syndrome	5.14e-05	0.000259	CcSEcCtD
Carbidopa—Pruritus—Oxcarbazepine—epilepsy syndrome	5.13e-05	0.000259	CcSEcCtD
Carbidopa—Convulsion—Pregabalin—epilepsy syndrome	5.12e-05	0.000259	CcSEcCtD
Carbidopa—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.12e-05	0.000258	CcSEcCtD
Carbidopa—Vision blurred—Gabapentin—epilepsy syndrome	5.11e-05	0.000258	CcSEcCtD
Carbidopa—Headache—Vigabatrin—epilepsy syndrome	5.11e-05	0.000258	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCG2—epilepsy syndrome	5.11e-05	0.000707	CbGpPWpGaD
Carbidopa—Hypertension—Pregabalin—epilepsy syndrome	5.11e-05	0.000258	CcSEcCtD
Carbidopa—Vomiting—Diazepam—epilepsy syndrome	5.11e-05	0.000258	CcSEcCtD
Carbidopa—Anorexia—Valproic Acid—epilepsy syndrome	5.09e-05	0.000257	CcSEcCtD
Carbidopa—Tremor—Gabapentin—epilepsy syndrome	5.08e-05	0.000256	CcSEcCtD
Carbidopa—Rash—Diazepam—epilepsy syndrome	5.06e-05	0.000255	CcSEcCtD
Carbidopa—Dermatitis—Diazepam—epilepsy syndrome	5.06e-05	0.000255	CcSEcCtD
Carbidopa—Chest pain—Pregabalin—epilepsy syndrome	5.03e-05	0.000254	CcSEcCtD
Carbidopa—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.03e-05	0.000254	CcSEcCtD
Carbidopa—Dizziness—Zonisamide—epilepsy syndrome	5.03e-05	0.000254	CcSEcCtD
Carbidopa—Headache—Diazepam—epilepsy syndrome	5.03e-05	0.000254	CcSEcCtD
Carbidopa—Anxiety—Pregabalin—epilepsy syndrome	5.02e-05	0.000253	CcSEcCtD
Carbidopa—Diarrhoea—Clonazepam—epilepsy syndrome	5.02e-05	0.000253	CcSEcCtD
Carbidopa—Anaemia—Gabapentin—epilepsy syndrome	5.01e-05	0.000253	CcSEcCtD
Carbidopa—Hypotension—Valproic Acid—epilepsy syndrome	4.99e-05	0.000252	CcSEcCtD
Carbidopa—Asthenia—Carbamazepine—epilepsy syndrome	4.99e-05	0.000252	CcSEcCtD
Carbidopa—Agitation—Gabapentin—epilepsy syndrome	4.98e-05	0.000251	CcSEcCtD
Carbidopa—Diarrhoea—Phenytoin—epilepsy syndrome	4.98e-05	0.000251	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP2C19—epilepsy syndrome	4.98e-05	0.000689	CbGpPWpGaD
Carbidopa—Discomfort—Pregabalin—epilepsy syndrome	4.97e-05	0.000251	CcSEcCtD
Carbidopa—Nausea—Fosphenytoin—epilepsy syndrome	4.97e-05	0.000251	CcSEcCtD
Carbidopa—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.00025	CcSEcCtD
Carbidopa—Angioedema—Gabapentin—epilepsy syndrome	4.96e-05	0.00025	CcSEcCtD
Carbidopa—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.95e-05	0.00025	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP11A1—epilepsy syndrome	4.95e-05	0.000684	CbGpPWpGaD
Carbidopa—Vomiting—Felbamate—epilepsy syndrome	4.94e-05	0.000249	CcSEcCtD
Carbidopa—Dry mouth—Pregabalin—epilepsy syndrome	4.92e-05	0.000248	CcSEcCtD
Carbidopa—Pruritus—Carbamazepine—epilepsy syndrome	4.92e-05	0.000248	CcSEcCtD
Carbidopa—Rash—Felbamate—epilepsy syndrome	4.9e-05	0.000247	CcSEcCtD
Carbidopa—Dermatitis—Felbamate—epilepsy syndrome	4.9e-05	0.000247	CcSEcCtD
Carbidopa—Malaise—Gabapentin—epilepsy syndrome	4.89e-05	0.000247	CcSEcCtD
Carbidopa—Headache—Felbamate—epilepsy syndrome	4.87e-05	0.000246	CcSEcCtD
Carbidopa—Confusional state—Pregabalin—epilepsy syndrome	4.87e-05	0.000246	CcSEcCtD
Carbidopa—Flushing—Topiramate—epilepsy syndrome	4.86e-05	0.000245	CcSEcCtD
Carbidopa—Syncope—Gabapentin—epilepsy syndrome	4.86e-05	0.000245	CcSEcCtD
Carbidopa—Leukopenia—Gabapentin—epilepsy syndrome	4.85e-05	0.000245	CcSEcCtD
Carbidopa—Dizziness—Clonazepam—epilepsy syndrome	4.85e-05	0.000245	CcSEcCtD
Carbidopa—Nausea—Vigabatrin—epilepsy syndrome	4.84e-05	0.000244	CcSEcCtD
Carbidopa—Vomiting—Zonisamide—epilepsy syndrome	4.84e-05	0.000244	CcSEcCtD
Carbidopa—Insomnia—Valproic Acid—epilepsy syndrome	4.83e-05	0.000244	CcSEcCtD
Carbidopa—Oedema—Pregabalin—epilepsy syndrome	4.83e-05	0.000244	CcSEcCtD
Carbidopa—Asthenia—Lamotrigine—epilepsy syndrome	4.82e-05	0.000243	CcSEcCtD
Carbidopa—Dizziness—Phenytoin—epilepsy syndrome	4.82e-05	0.000243	CcSEcCtD
Carbidopa—Rash—Zonisamide—epilepsy syndrome	4.8e-05	0.000242	CcSEcCtD
Carbidopa—Infection—Pregabalin—epilepsy syndrome	4.79e-05	0.000242	CcSEcCtD
Carbidopa—Paraesthesia—Valproic Acid—epilepsy syndrome	4.79e-05	0.000242	CcSEcCtD
Carbidopa—Palpitations—Gabapentin—epilepsy syndrome	4.79e-05	0.000242	CcSEcCtD
Carbidopa—Dermatitis—Zonisamide—epilepsy syndrome	4.79e-05	0.000242	CcSEcCtD
Carbidopa—Dizziness—Oxcarbazepine—epilepsy syndrome	4.79e-05	0.000242	CcSEcCtD
Carbidopa—Nausea—Diazepam—epilepsy syndrome	4.77e-05	0.000241	CcSEcCtD
Carbidopa—Loss of consciousness—Gabapentin—epilepsy syndrome	4.77e-05	0.00024	CcSEcCtD
Carbidopa—Headache—Zonisamide—epilepsy syndrome	4.77e-05	0.00024	CcSEcCtD
Carbidopa—Dyspnoea—Valproic Acid—epilepsy syndrome	4.76e-05	0.00024	CcSEcCtD
Carbidopa—Diarrhoea—Carbamazepine—epilepsy syndrome	4.76e-05	0.00024	CcSEcCtD
Carbidopa—Pruritus—Lamotrigine—epilepsy syndrome	4.75e-05	0.00024	CcSEcCtD
Carbidopa—Shock—Pregabalin—epilepsy syndrome	4.75e-05	0.00024	CcSEcCtD
Carbidopa—Somnolence—Valproic Acid—epilepsy syndrome	4.75e-05	0.000239	CcSEcCtD
Carbidopa—Cough—Gabapentin—epilepsy syndrome	4.73e-05	0.000239	CcSEcCtD
Carbidopa—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.73e-05	0.000238	CcSEcCtD
Carbidopa—Dyspepsia—Valproic Acid—epilepsy syndrome	4.7e-05	0.000237	CcSEcCtD
Carbidopa—Convulsion—Gabapentin—epilepsy syndrome	4.7e-05	0.000237	CcSEcCtD
Carbidopa—Hypertension—Gabapentin—epilepsy syndrome	4.68e-05	0.000236	CcSEcCtD
Carbidopa—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.67e-05	0.000235	CcSEcCtD
Carbidopa—Vomiting—Clonazepam—epilepsy syndrome	4.66e-05	0.000235	CcSEcCtD
Carbidopa—Decreased appetite—Valproic Acid—epilepsy syndrome	4.64e-05	0.000234	CcSEcCtD
Carbidopa—Alopecia—Topiramate—epilepsy syndrome	4.63e-05	0.000234	CcSEcCtD
Carbidopa—Vomiting—Phenytoin—epilepsy syndrome	4.63e-05	0.000234	CcSEcCtD
Carbidopa—Rash—Clonazepam—epilepsy syndrome	4.62e-05	0.000233	CcSEcCtD
Carbidopa—Dermatitis—Clonazepam—epilepsy syndrome	4.62e-05	0.000233	CcSEcCtD
Carbidopa—Chest pain—Gabapentin—epilepsy syndrome	4.62e-05	0.000233	CcSEcCtD
Carbidopa—Nausea—Felbamate—epilepsy syndrome	4.62e-05	0.000233	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.61e-05	0.000233	CcSEcCtD
Carbidopa—Vomiting—Oxcarbazepine—epilepsy syndrome	4.61e-05	0.000232	CcSEcCtD
Carbidopa—Fatigue—Valproic Acid—epilepsy syndrome	4.6e-05	0.000232	CcSEcCtD
Carbidopa—Anxiety—Gabapentin—epilepsy syndrome	4.6e-05	0.000232	CcSEcCtD
Carbidopa—Anorexia—Pregabalin—epilepsy syndrome	4.6e-05	0.000232	CcSEcCtD
Carbidopa—Dizziness—Carbamazepine—epilepsy syndrome	4.6e-05	0.000232	CcSEcCtD
Carbidopa—Diarrhoea—Lamotrigine—epilepsy syndrome	4.6e-05	0.000232	CcSEcCtD
Carbidopa—Headache—Clonazepam—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Carbidopa—Rash—Phenytoin—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Carbidopa—Mental disorder—Topiramate—epilepsy syndrome	4.59e-05	0.000232	CcSEcCtD
Carbidopa—Dermatitis—Phenytoin—epilepsy syndrome	4.59e-05	0.000231	CcSEcCtD
Carbidopa—Rash—Oxcarbazepine—epilepsy syndrome	4.57e-05	0.00023	CcSEcCtD
Carbidopa—Pain—Valproic Acid—epilepsy syndrome	4.57e-05	0.00023	CcSEcCtD
Carbidopa—Constipation—Valproic Acid—epilepsy syndrome	4.57e-05	0.00023	CcSEcCtD
Carbidopa—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.56e-05	0.00023	CcSEcCtD
Carbidopa—Headache—Phenytoin—epilepsy syndrome	4.56e-05	0.00023	CcSEcCtD
Carbidopa—Discomfort—Gabapentin—epilepsy syndrome	4.56e-05	0.00023	CcSEcCtD
Carbidopa—Headache—Oxcarbazepine—epilepsy syndrome	4.54e-05	0.000229	CcSEcCtD
Carbidopa—Nausea—Zonisamide—epilepsy syndrome	4.52e-05	0.000228	CcSEcCtD
Carbidopa—Dry mouth—Gabapentin—epilepsy syndrome	4.52e-05	0.000228	CcSEcCtD
Carbidopa—Hypotension—Pregabalin—epilepsy syndrome	4.51e-05	0.000228	CcSEcCtD
Carbidopa—Flatulence—Topiramate—epilepsy syndrome	4.5e-05	0.000227	CcSEcCtD
Carbidopa—Tension—Topiramate—epilepsy syndrome	4.48e-05	0.000226	CcSEcCtD
Carbidopa—Dysgeusia—Topiramate—epilepsy syndrome	4.47e-05	0.000225	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP2D6—epilepsy syndrome	4.46e-05	0.000618	CbGpPWpGaD
Carbidopa—Confusional state—Gabapentin—epilepsy syndrome	4.46e-05	0.000225	CcSEcCtD
Carbidopa—Dizziness—Lamotrigine—epilepsy syndrome	4.44e-05	0.000224	CcSEcCtD
Carbidopa—Nervousness—Topiramate—epilepsy syndrome	4.43e-05	0.000224	CcSEcCtD
Carbidopa—Oedema—Gabapentin—epilepsy syndrome	4.43e-05	0.000223	CcSEcCtD
Carbidopa—Vomiting—Carbamazepine—epilepsy syndrome	4.42e-05	0.000223	CcSEcCtD
Carbidopa—Back pain—Topiramate—epilepsy syndrome	4.41e-05	0.000223	CcSEcCtD
Carbidopa—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.4e-05	0.000222	CcSEcCtD
Carbidopa—Infection—Gabapentin—epilepsy syndrome	4.4e-05	0.000222	CcSEcCtD
Carbidopa—Muscle spasms—Topiramate—epilepsy syndrome	4.39e-05	0.000221	CcSEcCtD
Carbidopa—Rash—Carbamazepine—epilepsy syndrome	4.38e-05	0.000221	CcSEcCtD
Carbidopa—Dermatitis—Carbamazepine—epilepsy syndrome	4.38e-05	0.000221	CcSEcCtD
Carbidopa—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.37e-05	0.00022	CcSEcCtD
Carbidopa—Insomnia—Pregabalin—epilepsy syndrome	4.37e-05	0.00022	CcSEcCtD
Carbidopa—Nausea—Clonazepam—epilepsy syndrome	4.35e-05	0.00022	CcSEcCtD
Carbidopa—Headache—Carbamazepine—epilepsy syndrome	4.35e-05	0.00022	CcSEcCtD
Carbidopa—Shock—Gabapentin—epilepsy syndrome	4.35e-05	0.00022	CcSEcCtD
Carbidopa—Paraesthesia—Pregabalin—epilepsy syndrome	4.33e-05	0.000219	CcSEcCtD
Carbidopa—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.33e-05	0.000219	CcSEcCtD
Carbidopa—Nausea—Phenytoin—epilepsy syndrome	4.33e-05	0.000218	CcSEcCtD
Carbidopa—Dyspnoea—Pregabalin—epilepsy syndrome	4.3e-05	0.000217	CcSEcCtD
Carbidopa—Nausea—Oxcarbazepine—epilepsy syndrome	4.3e-05	0.000217	CcSEcCtD
Carbidopa—Vision blurred—Topiramate—epilepsy syndrome	4.3e-05	0.000217	CcSEcCtD
Carbidopa—Somnolence—Pregabalin—epilepsy syndrome	4.29e-05	0.000216	CcSEcCtD
Carbidopa—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.28e-05	0.000216	CcSEcCtD
Carbidopa—Tremor—Topiramate—epilepsy syndrome	4.27e-05	0.000216	CcSEcCtD
Carbidopa—Vomiting—Lamotrigine—epilepsy syndrome	4.27e-05	0.000216	CcSEcCtD
Carbidopa—DDC—Metabolism—ADRA2A—epilepsy syndrome	4.25e-05	0.000588	CbGpPWpGaD
Carbidopa—Urticaria—Valproic Acid—epilepsy syndrome	4.24e-05	0.000214	CcSEcCtD
Carbidopa—Rash—Lamotrigine—epilepsy syndrome	4.24e-05	0.000214	CcSEcCtD
Carbidopa—Ill-defined disorder—Topiramate—epilepsy syndrome	4.23e-05	0.000214	CcSEcCtD
Carbidopa—Dermatitis—Lamotrigine—epilepsy syndrome	4.23e-05	0.000214	CcSEcCtD
Carbidopa—DDC—Metabolism—BCHE—epilepsy syndrome	4.23e-05	0.000585	CbGpPWpGaD
Carbidopa—Abdominal pain—Valproic Acid—epilepsy syndrome	4.22e-05	0.000213	CcSEcCtD
Carbidopa—Body temperature increased—Valproic Acid—epilepsy syndrome	4.22e-05	0.000213	CcSEcCtD
Carbidopa—Anorexia—Gabapentin—epilepsy syndrome	4.22e-05	0.000213	CcSEcCtD
Carbidopa—Anaemia—Topiramate—epilepsy syndrome	4.22e-05	0.000213	CcSEcCtD
Carbidopa—Headache—Lamotrigine—epilepsy syndrome	4.21e-05	0.000212	CcSEcCtD
Carbidopa—Decreased appetite—Pregabalin—epilepsy syndrome	4.2e-05	0.000212	CcSEcCtD
Carbidopa—Agitation—Topiramate—epilepsy syndrome	4.19e-05	0.000212	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.17e-05	0.00021	CcSEcCtD
Carbidopa—Fatigue—Pregabalin—epilepsy syndrome	4.16e-05	0.00021	CcSEcCtD
Carbidopa—Hypotension—Gabapentin—epilepsy syndrome	4.14e-05	0.000209	CcSEcCtD
Carbidopa—Nausea—Carbamazepine—epilepsy syndrome	4.13e-05	0.000208	CcSEcCtD
Carbidopa—Pain—Pregabalin—epilepsy syndrome	4.13e-05	0.000208	CcSEcCtD
Carbidopa—Constipation—Pregabalin—epilepsy syndrome	4.13e-05	0.000208	CcSEcCtD
Carbidopa—Malaise—Topiramate—epilepsy syndrome	4.11e-05	0.000208	CcSEcCtD
Carbidopa—Syncope—Topiramate—epilepsy syndrome	4.09e-05	0.000206	CcSEcCtD
Carbidopa—Leukopenia—Topiramate—epilepsy syndrome	4.08e-05	0.000206	CcSEcCtD
Carbidopa—DDC—Metabolism—SLC2A1—epilepsy syndrome	4.04e-05	0.000558	CbGpPWpGaD
Carbidopa—Palpitations—Topiramate—epilepsy syndrome	4.03e-05	0.000203	CcSEcCtD
Carbidopa—Loss of consciousness—Topiramate—epilepsy syndrome	4.01e-05	0.000202	CcSEcCtD
Carbidopa—Insomnia—Gabapentin—epilepsy syndrome	4e-05	0.000202	CcSEcCtD
Carbidopa—DDC—Metabolism—PLCB1—epilepsy syndrome	3.99e-05	0.000552	CbGpPWpGaD
Carbidopa—Nausea—Lamotrigine—epilepsy syndrome	3.99e-05	0.000201	CcSEcCtD
Carbidopa—Cough—Topiramate—epilepsy syndrome	3.98e-05	0.000201	CcSEcCtD
Carbidopa—DDC—Metabolism—TH—epilepsy syndrome	3.98e-05	0.00055	CbGpPWpGaD
Carbidopa—Feeling abnormal—Pregabalin—epilepsy syndrome	3.98e-05	0.000201	CcSEcCtD
Carbidopa—Paraesthesia—Gabapentin—epilepsy syndrome	3.97e-05	0.000201	CcSEcCtD
Carbidopa—Convulsion—Topiramate—epilepsy syndrome	3.95e-05	0.000199	CcSEcCtD
Carbidopa—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.95e-05	0.000199	CcSEcCtD
Carbidopa—Dyspnoea—Gabapentin—epilepsy syndrome	3.95e-05	0.000199	CcSEcCtD
Carbidopa—Hypertension—Topiramate—epilepsy syndrome	3.94e-05	0.000199	CcSEcCtD
Carbidopa—Somnolence—Gabapentin—epilepsy syndrome	3.93e-05	0.000199	CcSEcCtD
Carbidopa—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.93e-05	0.000198	CcSEcCtD
Carbidopa—Dyspepsia—Gabapentin—epilepsy syndrome	3.9e-05	0.000197	CcSEcCtD
Carbidopa—Chest pain—Topiramate—epilepsy syndrome	3.88e-05	0.000196	CcSEcCtD
Carbidopa—Anxiety—Topiramate—epilepsy syndrome	3.87e-05	0.000195	CcSEcCtD
Carbidopa—Decreased appetite—Gabapentin—epilepsy syndrome	3.85e-05	0.000194	CcSEcCtD
Carbidopa—Discomfort—Topiramate—epilepsy syndrome	3.84e-05	0.000194	CcSEcCtD
Carbidopa—Urticaria—Pregabalin—epilepsy syndrome	3.83e-05	0.000193	CcSEcCtD
Carbidopa—Asthenia—Valproic Acid—epilepsy syndrome	3.83e-05	0.000193	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.82e-05	0.000193	CcSEcCtD
Carbidopa—Fatigue—Gabapentin—epilepsy syndrome	3.82e-05	0.000193	CcSEcCtD
Carbidopa—Abdominal pain—Pregabalin—epilepsy syndrome	3.82e-05	0.000192	CcSEcCtD
Carbidopa—Body temperature increased—Pregabalin—epilepsy syndrome	3.82e-05	0.000192	CcSEcCtD
Carbidopa—Dry mouth—Topiramate—epilepsy syndrome	3.8e-05	0.000192	CcSEcCtD
Carbidopa—Pain—Gabapentin—epilepsy syndrome	3.78e-05	0.000191	CcSEcCtD
Carbidopa—Constipation—Gabapentin—epilepsy syndrome	3.78e-05	0.000191	CcSEcCtD
Carbidopa—Pruritus—Valproic Acid—epilepsy syndrome	3.78e-05	0.000191	CcSEcCtD
Carbidopa—Confusional state—Topiramate—epilepsy syndrome	3.75e-05	0.000189	CcSEcCtD
Carbidopa—Oedema—Topiramate—epilepsy syndrome	3.72e-05	0.000188	CcSEcCtD
Carbidopa—Infection—Topiramate—epilepsy syndrome	3.7e-05	0.000187	CcSEcCtD
Carbidopa—Shock—Topiramate—epilepsy syndrome	3.66e-05	0.000185	CcSEcCtD
Carbidopa—Diarrhoea—Valproic Acid—epilepsy syndrome	3.65e-05	0.000184	CcSEcCtD
Carbidopa—Feeling abnormal—Gabapentin—epilepsy syndrome	3.65e-05	0.000184	CcSEcCtD
Carbidopa—Thrombocytopenia—Topiramate—epilepsy syndrome	3.65e-05	0.000184	CcSEcCtD
Carbidopa—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.62e-05	0.000183	CcSEcCtD
Carbidopa—Hyperhidrosis—Topiramate—epilepsy syndrome	3.6e-05	0.000182	CcSEcCtD
Carbidopa—Hypersensitivity—Pregabalin—epilepsy syndrome	3.56e-05	0.000179	CcSEcCtD
Carbidopa—Anorexia—Topiramate—epilepsy syndrome	3.55e-05	0.000179	CcSEcCtD
Carbidopa—Dizziness—Valproic Acid—epilepsy syndrome	3.53e-05	0.000178	CcSEcCtD
Carbidopa—Urticaria—Gabapentin—epilepsy syndrome	3.52e-05	0.000177	CcSEcCtD
Carbidopa—Body temperature increased—Gabapentin—epilepsy syndrome	3.5e-05	0.000177	CcSEcCtD
Carbidopa—Abdominal pain—Gabapentin—epilepsy syndrome	3.5e-05	0.000177	CcSEcCtD
Carbidopa—Hypotension—Topiramate—epilepsy syndrome	3.48e-05	0.000176	CcSEcCtD
Carbidopa—Asthenia—Pregabalin—epilepsy syndrome	3.46e-05	0.000175	CcSEcCtD
Carbidopa—Pruritus—Pregabalin—epilepsy syndrome	3.41e-05	0.000172	CcSEcCtD
Carbidopa—Vomiting—Valproic Acid—epilepsy syndrome	3.39e-05	0.000171	CcSEcCtD
Carbidopa—Insomnia—Topiramate—epilepsy syndrome	3.37e-05	0.00017	CcSEcCtD
Carbidopa—Rash—Valproic Acid—epilepsy syndrome	3.37e-05	0.00017	CcSEcCtD
Carbidopa—Dermatitis—Valproic Acid—epilepsy syndrome	3.36e-05	0.00017	CcSEcCtD
Carbidopa—Headache—Valproic Acid—epilepsy syndrome	3.34e-05	0.000169	CcSEcCtD
Carbidopa—Paraesthesia—Topiramate—epilepsy syndrome	3.34e-05	0.000169	CcSEcCtD
Carbidopa—DDC—Metabolism—HMOX1—epilepsy syndrome	3.32e-05	0.000459	CbGpPWpGaD
Carbidopa—Dyspnoea—Topiramate—epilepsy syndrome	3.32e-05	0.000167	CcSEcCtD
Carbidopa—Somnolence—Topiramate—epilepsy syndrome	3.31e-05	0.000167	CcSEcCtD
Carbidopa—Diarrhoea—Pregabalin—epilepsy syndrome	3.3e-05	0.000167	CcSEcCtD
Carbidopa—Dyspepsia—Topiramate—epilepsy syndrome	3.28e-05	0.000165	CcSEcCtD
Carbidopa—DDC—Metabolism—CAT—epilepsy syndrome	3.28e-05	0.000453	CbGpPWpGaD
Carbidopa—Hypersensitivity—Gabapentin—epilepsy syndrome	3.26e-05	0.000165	CcSEcCtD
Carbidopa—Decreased appetite—Topiramate—epilepsy syndrome	3.24e-05	0.000163	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.21e-05	0.000162	CcSEcCtD
Carbidopa—Fatigue—Topiramate—epilepsy syndrome	3.21e-05	0.000162	CcSEcCtD
Carbidopa—Dizziness—Pregabalin—epilepsy syndrome	3.19e-05	0.000161	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCB1—epilepsy syndrome	3.19e-05	0.000441	CbGpPWpGaD
Carbidopa—Pain—Topiramate—epilepsy syndrome	3.18e-05	0.000161	CcSEcCtD
Carbidopa—Constipation—Topiramate—epilepsy syndrome	3.18e-05	0.000161	CcSEcCtD
Carbidopa—Asthenia—Gabapentin—epilepsy syndrome	3.18e-05	0.00016	CcSEcCtD
Carbidopa—Nausea—Valproic Acid—epilepsy syndrome	3.17e-05	0.00016	CcSEcCtD
Carbidopa—Pruritus—Gabapentin—epilepsy syndrome	3.13e-05	0.000158	CcSEcCtD
Carbidopa—Vomiting—Pregabalin—epilepsy syndrome	3.07e-05	0.000155	CcSEcCtD
Carbidopa—Feeling abnormal—Topiramate—epilepsy syndrome	3.07e-05	0.000155	CcSEcCtD
Carbidopa—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.04e-05	0.000154	CcSEcCtD
Carbidopa—Rash—Pregabalin—epilepsy syndrome	3.04e-05	0.000154	CcSEcCtD
Carbidopa—Dermatitis—Pregabalin—epilepsy syndrome	3.04e-05	0.000153	CcSEcCtD
Carbidopa—Diarrhoea—Gabapentin—epilepsy syndrome	3.03e-05	0.000153	CcSEcCtD
Carbidopa—Headache—Pregabalin—epilepsy syndrome	3.02e-05	0.000153	CcSEcCtD
Carbidopa—DDC—Metabolism—GPX1—epilepsy syndrome	2.96e-05	0.00041	CbGpPWpGaD
Carbidopa—Urticaria—Topiramate—epilepsy syndrome	2.96e-05	0.000149	CcSEcCtD
Carbidopa—Abdominal pain—Topiramate—epilepsy syndrome	2.94e-05	0.000149	CcSEcCtD
Carbidopa—Body temperature increased—Topiramate—epilepsy syndrome	2.94e-05	0.000149	CcSEcCtD
Carbidopa—Dizziness—Gabapentin—epilepsy syndrome	2.93e-05	0.000148	CcSEcCtD
Carbidopa—Nausea—Pregabalin—epilepsy syndrome	2.87e-05	0.000145	CcSEcCtD
Carbidopa—Vomiting—Gabapentin—epilepsy syndrome	2.81e-05	0.000142	CcSEcCtD
Carbidopa—Rash—Gabapentin—epilepsy syndrome	2.79e-05	0.000141	CcSEcCtD
Carbidopa—Dermatitis—Gabapentin—epilepsy syndrome	2.79e-05	0.000141	CcSEcCtD
Carbidopa—Headache—Gabapentin—epilepsy syndrome	2.77e-05	0.00014	CcSEcCtD
Carbidopa—Hypersensitivity—Topiramate—epilepsy syndrome	2.74e-05	0.000138	CcSEcCtD
Carbidopa—Asthenia—Topiramate—epilepsy syndrome	2.67e-05	0.000135	CcSEcCtD
Carbidopa—Pruritus—Topiramate—epilepsy syndrome	2.63e-05	0.000133	CcSEcCtD
Carbidopa—Nausea—Gabapentin—epilepsy syndrome	2.63e-05	0.000133	CcSEcCtD
Carbidopa—DDC—Metabolism—AGT—epilepsy syndrome	2.6e-05	0.000359	CbGpPWpGaD
Carbidopa—Diarrhoea—Topiramate—epilepsy syndrome	2.55e-05	0.000129	CcSEcCtD
Carbidopa—DDC—Metabolism—APOE—epilepsy syndrome	2.55e-05	0.000352	CbGpPWpGaD
Carbidopa—Dizziness—Topiramate—epilepsy syndrome	2.46e-05	0.000124	CcSEcCtD
Carbidopa—Vomiting—Topiramate—epilepsy syndrome	2.37e-05	0.000119	CcSEcCtD
Carbidopa—Rash—Topiramate—epilepsy syndrome	2.35e-05	0.000118	CcSEcCtD
Carbidopa—Dermatitis—Topiramate—epilepsy syndrome	2.35e-05	0.000118	CcSEcCtD
Carbidopa—Headache—Topiramate—epilepsy syndrome	2.33e-05	0.000118	CcSEcCtD
Carbidopa—Nausea—Topiramate—epilepsy syndrome	2.21e-05	0.000112	CcSEcCtD
Carbidopa—DDC—Metabolism—POMC—epilepsy syndrome	2.19e-05	0.000303	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALB—epilepsy syndrome	1.99e-05	0.000276	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—epilepsy syndrome	1.74e-05	0.000241	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—epilepsy syndrome	8.77e-06	0.000121	CbGpPWpGaD
